May 24, 2016 / 11:26 AM / a year ago

BRIEF-Asterias Biotherapeutics says positive follow-up results from Phase 1 trial of AST-OPC1

May 24 (Reuters) - Asterias Biotherapeutics -

* Says positive long-term follow-up results from Phase 1 clinical trial assessing safety of AST-OPC1

* Delivery of AST-OPC1 was successful in all 5 patients with no serious adverse events associated with administration of cells Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below